-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We trim our 12-month target price by $4 to $48, valuing EQH shares at 6.8x our '26 operating EPS estimate of $7.10 (lowered today by $0.85) and at 5.5x our '27 EPS estimate of $8.75 (cut by $0.15), versus their one-year average forward multiple of 7x and a peer average of 9x. Q1 2026 EPS of $1.62 versus $1.30 a year ago beat the $1.61 consensus view but lagged our $1.85 estimate. Operating revenues declined 3%, versus our forecast of 3% to 8% growth, led by a 33% drop in policy fee revenues and 21% decline in premiums despite higher investment income and asset management fees. We view positively EQH's announced merger with Corebridge Financial (CRBG 28 NR) in an all-stock transaction closing by year-end 2026, where EQH shareholders will own 49% of the combined entity and receive 1.55516 shares per EQH share. Despite some merger-related uncertainty, we view the shares, currently trading at 6x our '26 EPS estimate (a discount to peer and historical averages) and yielding 2.5%, as undervalued.